Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 176 to 200 of 424

Guidance, NICE advice and quality standards in development
TitleTypeExpected publication date
Infigratinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangement [ID3992]Technology appraisal guidanceTBC
Insertion of neo-chordae into the beating heart for mitral regurgitationInterventional procedures guidanceTBC
Insulin icodec for treating type 2 diabetes [ID6175]Technology appraisal guidanceTBC
Intermittent urethral catheters for urinary management in adults : Late Stage AssessmentHealth technology evaluationTBC
Intrapartum Care - maternal hyponatremiaNICE guidelineTBC
Intrapartum care - uterotonics for postpartum haemorrhageNICE guideline
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary interventionInterventional procedures guidance
Iodine (131I)–apamistamab for treating relapsed or refractory acute myeloid leukaemia before an allogeneic haematopoietic stem cell transplant [ID6355]Technology appraisal guidanceTBC
Ipatasertib with abiraterone and prednisone for hormone-relapsed metastatic prostate cancer [ID3889]Technology appraisal guidanceTBC
Iptacopan for treating complement 3 glomerulopathy ID6283Technology appraisal guidanceTBC
Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable ID3981Technology appraisal guidance
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma [Review of TA658] [ID4067]Technology appraisal guidanceTBC
Ixazomib citrate for maintenance treatment of untreated multiple myeloma in people who cannot have autologous stem cell transplant [ID2706]Technology appraisal guidanceTBC
Kidney CancerQuality standardTBC
Kidney CancerNICE guidelineTBC
KTE-X19 for previously treated B-precursor acute lymphoblastic leukaemia in people aged 2 to 21 [ID1336]Technology appraisal guidanceTBC
Lacosamide for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy [ID1687]Technology appraisal guidanceTBC
Laparoscopic insertion of a non-active implant for gastro-oesophageal reflux diseaseInterventional procedures guidance
Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]Technology appraisal guidance
Lenadogene nolparvovec for treating Leber's hereditary optic neuropathy caused by the G11778A ND4 mitochondrial mutation [ID1410]Technology appraisal guidanceTBC
Leniolisib for activated phosphoinositide 3-kinase delta syndrome in people 12 years and over [ID6130]Highly specialised technology
Lenvatinib with pembrolizumab for untreated recurrent or advanced endometrial cancer [ID3966]Technology appraisal guidanceTBC
Leriglitazone for treating andrenoleukodystrophy [ID3903]Technology appraisal guidanceTBC
Letermovir for preventing cytomegalovirus infection after a kidney transplant [ID6166]Technology appraisal guidanceTBC
Leukocyte interleukin in combination for neoadjuvant treatment of resectable locally advanced squamous cell head and neck cancer [ID6390]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All